Myeloproliferative disorder Flashcards
Types
Over proliferation of myeloid cells:
Primary myelofibrosis (no dominant cell line, characteristic bone marrow fibrosis)
Polycythaemia vera (RBC)
Essential thrombocythaemia
Polycythemia Ruba Vera
Clinical Features
hyperviscosity
pruritus, typically after a hot bath
splenomegaly
haemorrhage (secondary to abnormal platelet function)
plethoric appearance (flushing)
Polycythaemia Ruba Vera
Investigations
FBC; raised Hb
Blood film
JAK2 mutation
Serum ferritin
U+Es and LFTs
If JAK 2 negative:
- serum erythropoietin level (which would be normal in polycythaemia vera)
- bone marrow aspirate and trephine (for myeloma\0
- cytogenetic analysis
Polycythaemia Vera
Management
Aspirin
Venesection - first line treatment
Hydroxyurea -slight increased risk of secondary leukaemia
Phosphorus-32 therapy
Essential Thrombocytosis
Features
platelet count > 600 * 109/l
both thrombosis (venous or arterial) and haemorrhage can be seen
a characteristic symptom is a burning sensation in the hands
a JAK2 mutation is found in around 50% of patients
Essential Thrombocytosis
Management
Hydroxyurea (hydroxycarbamide) is widely used to reduce the platelet count
Interferon-α is also used in younger patients
Low-dose aspirin may be used to reduce the thrombotic risk
Myelofibrosis
Pathology
Bone marrow is replaced with collagen (due to proliferation of megakaryocytes which releases fibroblast growth factor and stimulates collagen formation)
Can happen primarily or secondary due to e.g. leukaemia
Myelofibrosis
Clinical Features
Elderly person with symptoms of anaemia e.g. fatigue (the most common presenting symptom)
Massive splenomegaly: e.g. early satiety
Hypermetabolic symptoms due to the cytokines from megakaryocytes being released into system: weight loss, night sweats etc
Myelofibrosis
investigation
Anaemia
High WBC and platelet count early in the disease
‘tear-drop’ poikilocytes on blood film: due to RBC squeezing themselves out of the fibrotic bone marrow
Unobtainable bone marrow biopsy - ‘dry tap’ therefore trephine biopsy needed
High urate and LDH (reflect increased cell turnover)
Myelofibrosis
Management
Mostly palliative